What neuroenhancement really improves – and what only works subjectively better. Those who use cognitive performance-enhancing substances particularly frequently. Between Ritalin, Modafinil and coffee, the line between therapy and optimization is blurred. The article classifies prevalences, motivations and risks, explains the mechanisms of action of the most important substance classes and shows why the benefits are often overestimated, with practical tips for medical education in everyday life.
Autoren
- Dr. Ulf Blanke
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Atopic Dermatitis in Children and Adults
Topically Applied “Small Molecules”: Janus Kinases or PDE-4 as Targets?
- Dermatomyositis
Glucocorticoids for more than one year
- Diabetic Polyneuropathy
Clinical Presentation, Diagnosis, and Treatment of DSPN
- The Brain and the Motivation to Eat
Why is it so hard to lose weight?
- From symptom to diagnosis
Pulmonology – Lobus venae acygos
- Atopic Dermatitis: Precisely Targeting Immunological Targets
Interleukin blockade or OX40-(L) inhibition?
- Fibromyalgia Syndrome
Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
- Across All Types of Cancer